Description
Written by a preeminent expert in child and adolescent psychopharmacology, the Third Edition of this acclaimed reference is a current and authoritative clinical guide to the pediatric use of psychotropic drugs. This thoroughly revised edition covers the many new medications that have recently been approved, particularly antidepressants/SSRIs and atypical antipsychotics. Updated chapters on older drugs reflect important new studies, significant changes in recommended use, and new findings about off-label uses. Tables and charts throughout the book summarize practical information. A table on the front pages presents DMS-IV diagnoses, appropriate medications, and corresponding page references in the book.
Read More
Overviews issues to be considered before initiating psychiatric medication in children and adolescents, covering psychiatric diagnosis, target symptoms, informed consent, medico-legal considerations, and premedication baseline assessment. Major drug groups used in psychiatric practice are addressed, with reviews of issues surrounding drug administration, including titration, side effects, serum levels, monitoring, and discontinuation. This third edition discusses new topics, including the use of stimulants to treat Tourette's syndrome, and the risk of sudden death from tricyclic anti- depressants. Green teaches clinical psychiatry at New York University School of Medicine. Annotation c. Book News, Inc., Portland, OR (booknews.com)
Read Less